Sentry Petroleum Operating Income Over Time
| SPLM Stock | USD 0.0001 0.00 0.000003% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Sentry Petroleum Performance and Sentry Petroleum Correlation. Will Pharmaceuticals sector continue expanding? Could Sentry diversify its offerings? Factors like these will boost the valuation of Sentry Petroleum. If investors know Sentry will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Sentry Petroleum data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Sentry Petroleum is measured differently than its book value, which is the value of Sentry that is recorded on the company's balance sheet. Investors also form their own opinion of Sentry Petroleum's value that differs from its market value or its book value, called intrinsic value, which is Sentry Petroleum's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Sentry Petroleum's market value can be influenced by many factors that don't directly affect Sentry Petroleum's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sentry Petroleum's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sentry Petroleum is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Sentry Petroleum's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cross Equities Operating Income Analysis
Compare Sentry Petroleum and related stocks such as Cencora, Regeneron Pharmaceuticals, and IDEXX Laboratories Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| COR | 77.9 M | 1.3 B | 989 M | 1.2 B | 1.3 B | 1.7 B | 2 B | 1.7 B | 1.9 B | 2 B | 2.7 B | 2.8 B | 2.4 B | 3 B | 3.6 B | 4.2 B | 4.4 B |
| REGN | (3.3 M) | (205.2 M) | 457.7 M | 760 M | 838.4 M | 1.3 B | 1.3 B | 2.1 B | 2.5 B | 2.2 B | 3.6 B | 8.9 B | 5.4 B | 4 B | 4 B | 3.6 B | 3.8 B |
| IDXX | 2.6 M | 236.2 M | 262.6 M | 266.8 M | 260.3 M | 299.9 M | 350.2 M | 413 M | 491.3 M | 552.8 M | 694.5 M | 932 M | 898.8 M | 1.1 B | 1.1 B | 1.4 B | 1.4 B |
| HLN | 897 M | 897 M | 897 M | 897 M | 897 M | 897 M | 897 M | 897 M | 897 M | 897 M | 1.6 B | 1.6 B | 1.8 B | 2 B | 2.2 B | 2.5 B | 1.9 B |
| CI | (854.9 M) | 1.9 B | 2.9 B | 32.4 B | 11.6 B | 12.4 B | 3.1 B | 3.9 B | 4.2 B | 8.1 B | 8.2 B | 7.9 B | 8.4 B | 8.5 B | 9.4 B | 9.1 B | 9.6 B |
| ELV | 11.1 B | 4.5 B | 4.4 B | 4.7 B | 5.1 B | 5.4 B | 5.4 B | 5 B | 5.8 B | 6.7 B | 7.7 B | 8.9 B | 8.5 B | 8.7 B | 8.9 B | 8.1 B | 6.8 B |
| BDX | 137.7 M | 1.6 B | 1.3 B | 1.6 B | 1.1 B | 1.4 B | 1.5 B | 1.5 B | 1.8 B | 912 M | 2.2 B | 2.3 B | 2.1 B | 2.4 B | 2.6 B | 3 B | 3.1 B |
| ELAN | 5.4 M | 5.4 M | 5.4 M | 5.4 M | 5.4 M | 5.4 M | 283.2 M | 142.4 M | 313.8 M | 370 M | (76.8 M) | 304 M | 384 M | 326 M | 251 M | 288.6 M | 253.3 M |
| ARGX | (4.7 M) | (4.7 M) | (13.3 M) | (8.6 M) | (13.1 M) | (17.1 M) | (22.5 M) | (27.5 M) | (93.6 M) | (198.9 M) | (477.6 M) | (348.7 M) | (720.3 M) | (425 M) | (21.7 M) | (19.5 M) | (20.5 M) |
| TAK | 171.4 B | 265 B | 122.5 B | 139.3 B | (129.3 B) | 130.8 B | 155.9 B | 241.8 B | 205 B | 100.4 B | 509.3 B | 460.8 B | 490.5 B | 214.1 B | 342.6 B | 308.3 B | 226.9 B |
Sentry Petroleum and related stocks such as Cencora, Regeneron Pharmaceuticals, and IDEXX Laboratories Operating Income description
Operating Income is the amount of profit realized from Sentry Petroleum operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Sentry Petroleum is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Sentry Petroleum | SPLM |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 999 18th Street, |
| Exchange | OTCCE Exchange |
USD 1.0E-4
Check out Sentry Petroleum Performance and Sentry Petroleum Correlation. To learn how to invest in Sentry Stock, please use our How to Invest in Sentry Petroleum guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Sentry Petroleum technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.